You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

PIPERACILLIN AND TAZOBACTAM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Piperacillin And Tazobactam, and when can generic versions of Piperacillin And Tazobactam launch?

Piperacillin And Tazobactam is a drug marketed by Astral, Eugia Pharma, Eugia Pharma Speclts, Fresenius Kabi, Fresenius Kabi Usa, Hospira Inc, Istituto Bio Ita Spa, Provepharm Sas, Sagent Pharms Inc, Sandoz, Shandong, Steriscience Speclts, and Wockhardt Bio Ag. and is included in twenty-two NDAs.

The generic ingredient in PIPERACILLIN AND TAZOBACTAM is piperacillin sodium; tazobactam sodium. There are sixteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the piperacillin sodium; tazobactam sodium profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PIPERACILLIN AND TAZOBACTAM?
  • What are the global sales for PIPERACILLIN AND TAZOBACTAM?
  • What is Average Wholesale Price for PIPERACILLIN AND TAZOBACTAM?
Summary for PIPERACILLIN AND TAZOBACTAM
Drug patent expirations by year for PIPERACILLIN AND TAZOBACTAM
Recent Clinical Trials for PIPERACILLIN AND TAZOBACTAM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Scandinavian Critical Care Trials GroupPhase 4
University Hospital, RouenPhase 3
Wake Forest University Health SciencesPhase 4

See all PIPERACILLIN AND TAZOBACTAM clinical trials

Pharmacology for PIPERACILLIN AND TAZOBACTAM

US Patents and Regulatory Information for PIPERACILLIN AND TAZOBACTAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shandong PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 204959-003 Aug 10, 2018 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sandoz PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 065363-001 Oct 21, 2010 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wockhardt Bio Ag PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 207146-001 Mar 17, 2017 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.